cjc 1295/ipamorelin timeline CJC-1295 Results: Week-by-Week (2026) CJC-1295 / Ipamorelin Peptide Therapy:
Description
10.1016/j.gendis.2019.10.016 161 LimJ
Intriguingly, further investigation of the ATP7A T994I missense mutation, also linked to dHMN, revealed an abnormal interaction with valosin-containing protein 97 (p97/VCP), which, like AP1 and AP2, functions in endolysosomal trafficking (Bug & Meyer, 2012)
References 1 ZhengYLeySHHuFB
W.TsaiS
(Basel) 16 (6), 8892023
